
Evotec
Europe, Hamburg, Germany, Hamburg
Description
Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.
Investor Profile
Evotec has backed more than 27 startups, with 1 new investments in the last 12 months alone. The firm has led 5 rounds, about 19% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Germany.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series A (37%)
- Series B (22%)
- Series C (11%)
- Seed (11%)
- Series Unknown (7%)
- Corporate Round (4%)
- Post Ipo Equity (4%)
- Pre Seed (4%)
Country Focus
- United States (33%)
- United Kingdom (22%)
- Germany (22%)
- Ireland (7%)
- France (7%)
- Spain (4%)
- Italy (4%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Life Science
- Artificial Intelligence (Ai)
- Medical
- Oncology
- Genetics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Evotec frequently co-invest with?
What are some of recent deals done by Evotec?
Find More Investors Like Evotec
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










